These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

662 related items for PubMed ID: 26888116

  • 1. Melatonin alleviates acute lung injury through inhibiting the NLRP3 inflammasome.
    Zhang Y, Li X, Grailer JJ, Wang N, Wang M, Yao J, Zhong R, Gao GF, Ward PA, Tan DX, Li X.
    J Pineal Res; 2016 May; 60(4):405-14. PubMed ID: 26888116
    [Abstract] [Full Text] [Related]

  • 2. Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation.
    Li Y, Li H, Liu S, Pan P, Su X, Tan H, Wu D, Zhang L, Song C, Dai M, Li Q, Mao Z, Long Y, Hu Y, Hu C.
    Mol Immunol; 2018 Jul; 99():134-144. PubMed ID: 29783158
    [Abstract] [Full Text] [Related]

  • 3. Blocking triggering receptor expressed on myeloid cells-1 attenuates lipopolysaccharide-induced acute lung injury via inhibiting NLRP3 inflammasome activation.
    Liu T, Zhou Y, Li P, Duan JX, Liu YP, Sun GY, Wan L, Dong L, Fang X, Jiang JX, Guan CX.
    Sci Rep; 2016 Dec 22; 6():39473. PubMed ID: 28004759
    [Abstract] [Full Text] [Related]

  • 4. A novel synthetic derivative of melatonin, 5-hydroxy-2'-isobutyl-streptochlorin (HIS), inhibits inflammatory responses via regulation of TRIF-dependent signaling and inflammasome activation.
    Shim DW, Shin HJ, Han JW, Ji YE, Jang CH, Koppula S, Kang TB, Lee KH.
    Toxicol Appl Pharmacol; 2015 Apr 15; 284(2):227-35. PubMed ID: 25689174
    [Abstract] [Full Text] [Related]

  • 5. CORM-2 inhibits TXNIP/NLRP3 inflammasome pathway in LPS-induced acute lung injury.
    Jiang L, Fei D, Gong R, Yang W, Yu W, Pan S, Zhao M, Zhao M.
    Inflamm Res; 2016 Nov 15; 65(11):905-915. PubMed ID: 27412237
    [Abstract] [Full Text] [Related]

  • 6. Glycyrrhetinic acid alleviates acute lung injury by PI3K/AKT suppressing macrophagic Nlrp3 inflammasome activation.
    Wang K, Zhang Y, Cao Y, Shi Z, Lin Y, Chen Y, Zhao H, Liu X.
    Biochem Biophys Res Commun; 2020 Nov 19; 532(4):555-562. PubMed ID: 32900490
    [Abstract] [Full Text] [Related]

  • 7. Dynasore Alleviates LPS-Induced Acute Lung Injury by Inhibiting NLRP3 Inflammasome-Mediated Pyroptosis.
    Shan M, Wan H, Ran L, Ye J, Xie W, Lu J, Hu X, Deng S, Zhang W, Chen M, Wang F, Guo Z.
    Drug Des Devel Ther; 2024 Nov 19; 18():1369-1384. PubMed ID: 38681210
    [Abstract] [Full Text] [Related]

  • 8. Resveratrol ameliorates LPS-induced acute lung injury via NLRP3 inflammasome modulation.
    Jiang L, Zhang L, Kang K, Fei D, Gong R, Cao Y, Pan S, Zhao M, Zhao M.
    Biomed Pharmacother; 2016 Dec 19; 84():130-138. PubMed ID: 27643555
    [Abstract] [Full Text] [Related]

  • 9. Apelin-13 Administration Protects Against LPS-Induced Acute Lung Injury by Inhibiting NF-κB Pathway and NLRP3 Inflammasome Activation.
    Zhang H, Chen S, Zeng M, Lin D, Wang Y, Wen X, Xu C, Yang L, Fan X, Gong Y, Zhang H, Kong X.
    Cell Physiol Biochem; 2018 Dec 19; 49(5):1918-1932. PubMed ID: 30235451
    [Abstract] [Full Text] [Related]

  • 10. Anti-inflammatory effect of Impatiens textori Miq. extract via inhibition of NLRP3 inflammasome activation in in vitro and in vivo experimental models.
    Sun X, Shim DW, Han JW, Shin WY, Sim EJ, Kim MK, Heo KH, Kim YK, Koppula S, Kim TJ, Kang TB, Lee KH.
    J Ethnopharmacol; 2015 Jul 21; 170():81-7. PubMed ID: 25975512
    [Abstract] [Full Text] [Related]

  • 11. Fn14 exacerbates acute lung injury by activating the NLRP3 inflammasome in mice.
    Guan XX, Yang HH, Zhong WJ, Duan JX, Zhang CY, Jiang HL, Xiang Y, Zhou Y, Guan CX.
    Mol Med; 2022 Jul 30; 28(1):85. PubMed ID: 35907805
    [Abstract] [Full Text] [Related]

  • 12. Corticosteroids alleviate lipopolysaccharide-induced inflammation and lung injury via inhibiting NLRP3-inflammasome activation.
    Yang JW, Mao B, Tao RJ, Fan LC, Lu HW, Ge BX, Xu JF.
    J Cell Mol Med; 2020 Nov 30; 24(21):12716-12725. PubMed ID: 32977368
    [Abstract] [Full Text] [Related]

  • 13. Implication of mitochondrial ROS-NLRP3 inflammasome axis during two-hit mediated acute lung injury in mice.
    Puri G, Naura AS.
    Free Radic Res; 2022 Jan 30; 56(1):1-16. PubMed ID: 35129032
    [Abstract] [Full Text] [Related]

  • 14. Vasoactive intestinal peptide suppresses the NLRP3 inflammasome activation in lipopolysaccharide-induced acute lung injury mice and macrophages.
    Zhou Y, Zhang CY, Duan JX, Li Q, Yang HH, Sun CC, Zhang J, Luo XQ, Liu SK.
    Biomed Pharmacother; 2020 Jan 30; 121():109596. PubMed ID: 31731193
    [Abstract] [Full Text] [Related]

  • 15. Loganin alleviates sepsis-induced acute lung injury by regulating macrophage polarization and inhibiting NLRP3 inflammasome activation.
    Zhang J, Wang C, Wang H, Li X, Xu J, Yu K.
    Int Immunopharmacol; 2021 Jun 30; 95():107529. PubMed ID: 33744777
    [Abstract] [Full Text] [Related]

  • 16. A COX-2/sEH dual inhibitor PTUPB alleviates lipopolysaccharide-induced acute lung injury in mice by inhibiting NLRP3 inflammasome activation.
    Yang HH, Duan JX, Liu SK, Xiong JB, Guan XX, Zhong WJ, Sun CC, Zhang CY, Luo XQ, Zhang YF, Chen P, Hammock BD, Hwang SH, Jiang JX, Zhou Y, Guan CX.
    Theranostics; 2020 Jun 30; 10(11):4749-4761. PubMed ID: 32308747
    [Abstract] [Full Text] [Related]

  • 17. Xuanbai Chengqi Decoction alleviates acute lung injury by inhibiting NLRP3 inflammasome.
    Wang S, Lin F, Zhang C, Gao D, Qi Z, Wu S, Wang W, Li X, Pan L, Xu Y, Tan B, Yang A.
    J Ethnopharmacol; 2024 Jan 30; 319(Pt 2):117227. PubMed ID: 37751794
    [Abstract] [Full Text] [Related]

  • 18. RIP3 dependent NLRP3 inflammasome activation is implicated in acute lung injury in mice.
    Chen J, Wang S, Fu R, Zhou M, Zhang T, Pan W, Yang N, Huang Y.
    J Transl Med; 2018 Aug 20; 16(1):233. PubMed ID: 30126430
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Critical role for the NLRP3 inflammasome during acute lung injury.
    Grailer JJ, Canning BA, Kalbitz M, Haggadone MD, Dhond RM, Andjelkovic AV, Zetoune FS, Ward PA.
    J Immunol; 2014 Jun 15; 192(12):5974-83. PubMed ID: 24795455
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.